CUSIP 15117B202COM NEWCLDXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
185 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Wellington Management Group LLP | 8.08M | $219.44M | +2.28M | Added |
| 2 | Kynam Capital Management, LP | 5.94M | $161.42M | −157.5K | Reduced |
| 3 | Blackrock, Inc. | 5.45M | $148.07M | −54.2K | Reduced |
| 4 | Fmr LLC | 4.91M | $133.29M |
| −54.6K |
| Reduced |
| 5 | Vanguard Group Inc | 4.03M | $109.38M | +72.8K | Added |
| 6 | Bellevue Group AG | 3.62M | $98.26M | +60.0K | Added |
| 7 | State Street Corp | 3.40M | $92.28M | +555.6K | Added |
| 8 | Commodore Capital LP | 2.56M | $69.67M | −463.3K | Reduced |
| 9 | Deep Track Capital, LP | 1.90M | $51.62M | −99.3K | Reduced |
| 10 | Braidwell LP | 1.86M | $50.47M | +1.27M | Added |
See every fund holding Celldex Therapeutics Inc New, with full quarter-over-quarter share changes.
Unlock all holders